Back to Top Skip to main content

Policies

You can use the left hand navigation box to find policies by year or find specific policies by using the keyword search below.

Search Policies

DoDEA Influenza Vaccine Requirement

Policy

IP-008: Submission of Reportable Events to R2O2 Information Paper

Policy

This info paper describes the policy and requirements for the Submission of Reportable Events to R2O2.

USEUCOM GENADMIN 2016-17 Influenza (Flu) Prevention and Control

Policy

I MEF 2016-17 ANNUAL INFLUENZA VACCINE GUIDANCE

Policy

ALCOAST 2016-2017 ANNUAL INFLUENZA IMMUNIZATION PROGRAM

Policy

BUMED 2016 2017 SEASONAL INFLUENZA MESSAGE

Policy

NAVADMIN 2016-2017 NAVY INFLUENZA VACCINATION AND REPORTING POLICY

Policy

FY17 Continued Health Care Benefit Program Quarterly Premium Rates

Policy

Policy Memorandum to Establish 2017 Quarterly Premium Rates for the Continued Health Care Benefit Program

  • Identification #: N/A
  • Date: 8/17/2016
  • Type: Memorandums
  • Topics: N/A

DHA-IPM 16-002: Seasonal Influenza Vaccination Program

Policy

This Interim Procedures Memorandum provides guideance for the 2016-2017 seasonal influenza vaccination program.

  • Identification #: DHA-IPM 16-002
  • Date: 8/11/2016
  • Type: DHA Interim Procedures Memorandum
  • Topics: Influenza Seasonal

2016-2017 Department of Defense Influenza Surveillance Program Sentinel Sites

Policy

The DoD Global, Laboratory-based, Influenza Surveillance Program, at USAFSAM selects military treatment facilities (MTFs) from worldwide locations to participate as Sentinel Sites. Installations are selected annually based on mission, population, deployment/operations tempo and type, and geographic location. Particular focus is on impact to critical operations, highly heterogeneous, mobile populations, potential for new strain production, and past performance. The 2016-2017 Sentinel Site listing (attached) was approved by the USAFSAM team in April 2016, in committee, and has remained unchanged for 2 years.

Interim AMEDD Guidance for Trangender Medical Care

Policy

This memo provides interim guidance regarding the medical evaluation and treatment of active duty transgender Service Members.

  • Identification #: OTSG/MEDCOM Policy Memo 16-060
  • Date: 8/3/2016
  • Type: Memorandums
  • Topics: N/A

Guidance for the Treatment of Gender Dysphoria for Active and Reserve Component Service Members

Policy

In accordance with Department of Defense Instruction (DoDI) 1300.28, "In-Service Transition for Transgender Service Members" June 30, 2016, and Directive-Type Memorandum (DTM) 16-005, "Military Service of Transgender Service Members," June 30, 2016, this memorandum provides guidance for the medical care of transgender Service members. This memorandum supplements requirements in those issuances; it does not supersede any such requirements. Until the DoD is able to promulgate specific clinical practice guidelines fro the care of transgender personnel, the Military Health System will adhere to the 2009 version of the Endocrine Society's Standards of Care, "Endocrine Treatment of Transsexual Persons: An Endocrine Society's Clinical Practice Guideline" as the primary guideline to provide consistent, evidence-based care to transitioning patients. Please visit the National Institutes of Health Website for a copy of these clinical practice guidelines: http://www.ncbi.nlm.nih.gov/pubmed/19509099

  • Identification #: N/A
  • Date: 7/29/2016
  • Type: Memorandums
  • Topics: N/A

Interim Guidance for Prevention of Sexual Transmission of Zika Virus

Policy

With this update, CDC is expanding its existing recommendations to cover all pregnant couples, which includes pregnant women with female sex partners. This guidance also describes what other couples (those who are not pregnant or planning to become pregnant) can do to reduce the risk for Zika virus transmission. CDC’s recommendations for couples planning to become pregnant have been published separately (9).

Directive Type Memorandum: Military Service of Transgender Service Members

Policy

This DTM establishes policy, assigns responsibilities and prescribes procedures for the standards for retention, accession, separation, in-service transition and medical coverage for transgender personnel serving in the Military services.

  • Identification #: DTM 16-005
  • Date: 6/30/2016
  • Type: Directives
  • Topics: N/A

DoD Instruction 6025.13: Medical Quality Assurance (MQA) and Clinical Quality Management in the Military Health System (MHS) Instruction

Policy

This Department of Defense Instruction (Number 6025.13) establishes DoD policy on issues related to MQA programs and clinical quality management activities.

<< < 1 2 3 4 5  ... > >> 
Showing results 46 - 60 Page 4 of 70

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.